Assignee
NEVADA CANCER INST
US·1 granted patent·3 pending applications·6 citations·filing 2006–2008
Top patents by PatentIndex Score
4 records- 0178US7790407B2Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)NEVADA CANCER INST·Filed 2006·Granted Sep 7, 2010·6 cites·5 claims
- 0253US2008299077A1Isolation and growth of stem cells from hemangiomasNEVADA CANCER INST·Filed 2008·Application pending·0 cites
- 0342US2008182806A1Use of acetylated or esterificated azacytidine, decitabine, or other nucleoside analogs as oral agents for the treatment of tumors or other dysplastic syndromes sensitive to hypomethylating agentsNEVADA CANCER INST·Filed 2008·Application pending·0 cites
- 0441US2008241110A1Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)NEVADA CANCER INST·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEVADA CANCER INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →